PharmaLundensis

0.05 SEK

-1.88 %

Less than 1K followers

PHAL

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

-1.88 %
-59.85 %
-79.20 %
-78.78 %
-87.72 %
-90.08 %
-89.50 %
-92.72 %
-98.41 %

PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.

Read more
Market cap
3.36M SEK
Turnover
15.5K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28/5
2026

Interim report Q1'26

25/6
2026

General meeting '26

20/8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.